Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Neuroscience ; 131(4): 917-33, 2005.
Article in English | MEDLINE | ID: mdl-15749345

ABSTRACT

GABA-A and GABA-B receptors mediate differential effects in the CNS. To better understand the role of these receptors in regulating pallidal functions, we compared their subcellular and subsynaptic localization in the external and internal segments of the globus pallidus (GPe and GPi) in monkeys, using pre- and post-embedding immunocytochemistry with antibodies against GABA-A (alpha1, beta2/3 subunits) and GABA-BR1 receptor subtype. Our results demonstrate that GABA-A and GABA-B receptors display a differential pattern of subcellular and subsynaptic localization in both segments of the globus pallidus. The majority of GABA-BR1 immunolabeling is intracellular, whereas immunoreactivity for GABA-A receptor subunits is mostly bound to the plasma membrane. A significant proportion of both GABA-BR1 and GABA-A receptor immunolabeling is extrasynaptic, but GABA-A receptor subunits also aggregate in the main body of putative GABAergic symmetric synapses established by striatal- and pallidal-like terminals. GABA-BR1 immunoreactivity is expressed presynaptically in putative glutamatergic terminals, while GABA-A alpha1 and beta2/3 receptor subunits are exclusively post-synaptic and often coexist at individual symmetric synapses in both GPe and GPi. In conclusion, our findings corroborate the concept that ionotropic and metabotropic GABA receptors are located to subserve different effects in pallidal neurons. Although the aggregation of GABA-A receptors at symmetric synapses is consistent with their role in fast inhibitory synaptic transmission, the extrasynaptic distribution of both GABA-A and GABA-B receptors provides a substrate for complex modulatory functions that rely predominantly on the spillover of GABA.


Subject(s)
Globus Pallidus/metabolism , Receptors, GABA-A/metabolism , Receptors, GABA-B/metabolism , Synapses/metabolism , Animals , Cell Membrane/metabolism , Globus Pallidus/ultrastructure , Immunoenzyme Techniques , Immunohistochemistry , Macaca mulatta , Male , Microscopy, Electron , Neurons/metabolism , Neurons/ultrastructure , Subcellular Fractions/metabolism , Tissue Embedding
2.
Neuroscience ; 127(3): 709-21, 2004.
Article in English | MEDLINE | ID: mdl-15283969

ABSTRACT

The activation of GABA receptor subtype A (GABA(A)) and GABA receptor subtype B (GABA(B)) receptors mediates differential effects on GABAergic and non-GABAergic transmission in the basal ganglia. To further characterize the anatomical substrate that underlies these functions, we used immunogold labeling to compare the subcellular and subsynaptic localization of GABA(A) and GABA(B) receptors in the subthalamic nucleus (STN). Our findings demonstrate major differences and some similarities in the distribution of GABA(A) and GABA(B) receptors in the monkey STN. The immunoreactivity for GABA(A) receptor alpha1 subunits is mostly bound to the plasma membrane, whereas GABA(B) R1 subunit alpha1 immunoreactivity is largely expressed intracellularly. Plasma membrane-bound GABA(A) alpha1 subunit aggregate in the main body of putative GABAergic synapses, while GABA(B) R1 receptors are found at the edges of putative glutamatergic or GABAergic synapses. A large pool of plasma membrane-bound GABA(A) and GABA(B) receptors is extrasynaptic. In conclusion, these findings demonstrate a significant degree of heterogeneity between the distributions of the two major GABA receptor subtypes in the monkey STN. Their pattern of synaptic localization puts forward interesting questions regarding their mechanisms of activation and functions at GABAergic and non-GABAergic synapses.


Subject(s)
Receptors, GABA-A/metabolism , Receptors, GABA-B/metabolism , Subthalamic Nucleus/metabolism , Synapses/metabolism , Animals , Cell Membrane/metabolism , Immunohistochemistry , Macaca mulatta , Macaca nemestrina , Male , Microscopy, Immunoelectron , Synapses/ultrastructure , Synaptic Transmission/physiology
3.
Neuropsychopharmacology ; 28(8): 1412-21, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12799620

ABSTRACT

The nucleus accumbens (NAc) receives excitatory afferents from several cortical and limbic regions and dense dopaminergic inputs from the ventral tegmental area. We examined the effects of dopamine (DA) D1 and D2 selective drugs on the responses evoked in the NAc shell neurons recorded in vitro by stimulation of hippocampal and amygdaloid afferents. Activation of hippocampal and amygdaloid afferents induced excitatory postsynaptic responses that were depressed by bath application of DA in most of the cells recorded. The DA effect was substantially blocked by the D1 receptor antagonist SCH 23390, but not by the D2 receptor antagonist eticlopride. Moreover, the D1 receptor agonist SKF 38393, but not the D2 receptor agonist quinpirole, mimicked the effects of DA, although a small population of neurons exhibited a D1-mediated facilitation of the EPSP amplitude following fornix stimulation. These data demonstrate a DA receptor subtype-specific modulation of glutamatergic inputs to the NAc, with D1 agonists attenuating amygdaloid inputs, whereas hippocampal-evoked responses were either depressed or potentiated by D1 stimulation. Such facilitation or attenuation of hippocampal afferents against a background of suppression of other afferents would permit the hippocampus to have a dominant influence over behavior during periods of exploration.


Subject(s)
Amygdala/physiology , Hippocampus/physiology , Neurons/physiology , Nucleus Accumbens/physiology , Receptors, Dopamine/physiology , Afferent Pathways/drug effects , Afferent Pathways/physiology , Amygdala/drug effects , Animals , Dopamine Agonists/pharmacology , Hippocampus/drug effects , Male , Neurons/drug effects , Nucleus Accumbens/drug effects , Rats , Rats, Sprague-Dawley
4.
J Neurosci ; 21(22): 8746-57, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11698586

ABSTRACT

The localization and functions of kainate receptors (KARs) in the CNS are still poorly known. In the striatum, GluR6/7 and KA2 immunoreactivity is expressed presynaptically in a subpopulation of glutamatergic terminals and postsynaptically in dendrites and spines. The goal of this study was to further characterize the subcellular and subsynaptic localization of kainate receptor subunits in the monkey striatum. Immunoperoxidase data reveal that the relative abundance of GluR6/7- and KA2-immunoreactive terminals is homogeneous throughout the striatum irrespective of the differential degree of striatal degeneration in Huntington's disease. Pre-embedding and post-embedding immunogold data indicate that >70% of the presynaptic or postsynaptic GluR6/7 and KA2 labeling is expressed intracellularly. In material stained with the post-embedding immunogold method, approximately one-third of plasma membrane-bound gold particles labeling in axon terminals and spines is associated with asymmetric synapses, thereby representing synaptic kainate receptor subunits. On the other hand, >60% of the plasma-membrane bound labeling is extrasynaptic. Both GluR6/7 and KA2 labeling in glutamatergic terminals often occurs in clusters of gold particles along the membrane of large vesicular organelles located at various distances from the presynaptic grid. Anterograde labeling from the primary motor cortex or the centromedian thalamic nucleus indicate that both corticostriatal and thalamostriatal terminals express presynaptic GluR6/7 and KA2 immunoreactivity in the postcommissural putamen. In conclusion, these data demonstrate that kainate receptors in the striatum display a pattern of subcellular distribution different from other ionotropic glutamate receptor subtypes, but consistent with their metabotropic-like functions recently shown in the hippocampus.


Subject(s)
Biotin/analogs & derivatives , Corpus Striatum/metabolism , Protein Subunits , Receptors, Kainic Acid/biosynthesis , Synapses/metabolism , Animals , Antibody Specificity , Blotting, Western , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Corpus Striatum/ultrastructure , Dextrans , Immunohistochemistry , Macaca mulatta , Male , Microscopy, Immunoelectron , Neurons/metabolism , Neurons/ultrastructure , Organelles/metabolism , Organelles/ultrastructure , Receptors, Kainic Acid/analysis , Saimiri , Synapses/ultrastructure , GluK2 Kainate Receptor , GluK3 Kainate Receptor
5.
J Chem Neuroanat ; 22(1-2): 13-42, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11470552

ABSTRACT

The functions of glutamate and GABA in the CNS are mediated by ionotropic and metabotropic, G protein-coupled, receptors. Both receptor families are widely expressed in basal ganglia structures in primates and nonprimates. The recent development of highly specific antibodies and/or cDNA probes allowed the better characterization of the cellular localization of various GABA and glutamate receptor subtypes in the primate basal ganglia. Furthermore, the use of high resolution immunogold techniques at the electron microscopic level led to major breakthroughs in our understanding of the subsynaptic and subcellular localization of these receptors in primates. In this review, we will provide a detailed account of the current knowledge of the localization of these receptors in the basal ganglia of humans and monkeys.


Subject(s)
Basal Ganglia/metabolism , Primates/metabolism , Receptors, GABA/metabolism , Receptors, Metabotropic Glutamate/metabolism , Synapses/metabolism , Animals , Basal Ganglia/ultrastructure , Glutamic Acid/metabolism , Humans , Neural Pathways/metabolism , Neural Pathways/ultrastructure , Primates/anatomy & histology , Synapses/ultrastructure , gamma-Aminobutyric Acid/metabolism
6.
J Anat ; 196 ( Pt 4): 555-76, 2000 May.
Article in English | MEDLINE | ID: mdl-10923987

ABSTRACT

Glutamate and GABA neurotransmission is mediated through various types of ionotropic and metabotropic receptors. In this review, we summarise some of our recent findings on the subcellular and subsynaptic localisation of GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex of monkeys. Polyclonal antibodies that specifically recognise GABA(B)R1, mGluR1a and mGluR5 receptor subtypes were used for immunoperoxidase and pre-embedding immunogold techniques at the light and electron microscope levels. Both subtypes of group I mGluRs were expressed postsynaptically in striatal projection neurons and interneurons where they aggregate perisynaptically at asymmetric glutamatergic synapses and symmetric dopaminergic synaptic junctions. Moreover, they are also strongly expressed in the main body of symmetric synapses established by putative intrastriatal GABAergic terminals. In the globus pallidus, both receptor subtypes are found postsynaptically in the core of striatopallidal GABAergic synapses and perisynaptically at subthalamopallidal glutamatergic synapses. Finally, extrasynaptic labelling was commonly seen in the globus pallidus and the striatum. Moderate to intense GABA(B)R1 immunoreactivity was observed in the striatopallidal complex. At the electron microscope level, GABA(B)R1 immunostaining was commonly found in neuronal cell bodies and dendrites. Many striatal dendritic spines also displayed GABA(B)R1 immunoreactivity. Moreover, GABA(B)R1-immunoreactive axons and axon terminals were frequently encountered. In the striatum, GABA(B)R1-immunoreactive boutons resembled terminals of cortical origin, while in the globus pallidus, subthalamic-like terminals were labelled. Pre-embedding immunogold data showed that postsynaptic GABA(B)R1 receptors are concentrated at extrasynaptic sites on dendrites, spines and somata in the striatopallidal complex, perisynaptically at asymmetric synapses and in the main body of symmetric striatopallidal synapses in the GPe and GPi. Consistent with the immunoperoxidase data, immunoparticles were found in the presynaptic grid of asymmetric synapses established by cortical- and subthalamic-like glutamatergic terminals. These findings indicate that both GABA and glutamate metabotropic receptors are located to subserve various modulatory functions of the synaptic transmission in the primate striatopallidal complex. Furthermore, their pattern of localisation raises issues about their roles and mechanisms of activation in normal and pathological conditions. Because of their 'modulatory' functions, these receptors are ideal targets for chronic drug therapies in neurodegenerative diseases such as Parkinson's disease.


Subject(s)
Corpus Striatum/metabolism , Primates/metabolism , Receptors, GABA-B/metabolism , Receptors, Glutamate/metabolism , Animals , Globus Pallidus/metabolism , Microscopy, Immunoelectron , Neostriatum/metabolism , Neurotransmitter Agents/metabolism , Parkinson Disease/drug therapy , Synapses/metabolism
7.
Neuroscience ; 95(1): 127-40, 2000.
Article in English | MEDLINE | ID: mdl-10619469

ABSTRACT

GABAergic neurotransmission involves ionotropic GABA(A) and metabotropic GABA(B) receptor subtypes. Although fast inhibitory transmission through GABA(A) receptors activation is commonly found in the basal ganglia, the functions as well as the cellular and subcellular localization of GABA(B) receptors are still poorly known. Polyclonal antibodies that specifically recognize the GABA(B)R1 receptor subunit were produced and used for immunocytochemical localization of these receptors at the light and electron microscope levels in the monkey basal ganglia. Western blot analysis of monkey brain homogenates revealed that these antibodies reacted specifically with two native proteins corresponding to the size of the two splice variants GABA(B)R1a and GABA(B)R1b. Preadsorption of the purified antiserum with synthetic peptides demonstrated that these antibodies recognize specifically GABA(B)R1 receptors with no cross-reactivity with GABA(B)R2 receptors. Overall, the distribution of GABA(B)R1 immunoreactivity throughout the monkey brain correlates with previous GABA(B) ligand binding studies and in situ hybridization data as well as with recent immunocytochemical studies in rodents. GABA(B)R1-immunoreactive cell bodies were found in all basal ganglia nuclei but the intensity of immunostaining varied among neuronal populations in each nucleus. In the striatum, interneurons were more strongly stained than medium-sized projection neurons while in the substantia nigra, dopaminergic neurons of the pars compacta were much more intensely labeled than GABAergic neurons of the pars reticulata. In the subthalamic nucleus, clear immunonegative neuronal perikarya were intermingled with numerous GABA(B)R1-immunoreactive cells. Moderate GABA(B)R1 immunoreactivity was observed in neuronal perikarya and dendritic processes throughout the external and internal pallidal segments. At the electron microscope level, GABA(B)R1 immunoreactivity was commonly found in neuronal cell bodies and dendrites in every basal ganglia nuclei. Many dendritic spines also displayed GABA(B)R1 immunoreactivity in the striatum. In addition to strong postsynaptic labeling, GABA(B)R1-immunoreactive preterminal axonal segments and axon terminals were frequently encountered throughout the basal ganglia components. The majority of labeled terminals displayed the ultrastructural features of glutamatergic boutons and formed asymmetric synapses. In the striatum, GABA(B)R1-containing boutons resembled terminals of cortical origin, while in the globus pallidus and substantia nigra, subthalamic-like terminals were labeled. Overall, these findings demonstrate that GABA(B) receptors are widely distributed and located to subserve both pre- and postsynaptic roles in controlling synaptic transmission in the primate basal ganglia.


Subject(s)
Basal Ganglia/metabolism , Presynaptic Terminals/metabolism , Receptors, GABA-B/metabolism , Synapses/metabolism , Animals , Corpus Striatum/metabolism , Globus Pallidus/metabolism , Immunoblotting , Immunohistochemistry/methods , Macaca mulatta , Male , Staining and Labeling , Substantia Nigra/metabolism , Thalamic Nuclei/metabolism , Tissue Distribution
8.
Neuroscience ; 91(4): 1195-200, 1999.
Article in English | MEDLINE | ID: mdl-10391427

ABSTRACT

Although kainate has long been known as a powerful axon-sparing neurotoxin, the localization and functions of kainate receptors in the CNS are largely unknown. In the present study we examined the distribution of kainate receptor subunits in the monkey striatum using kainate receptor subunits GluR6/7 and kainate receptor subunit KA2 subunit antibodies at the electron microscope level. We found that kainate receptor subunits GluR6/7 immunoreactivity is expressed not only in neuronal perikarya and dendritic processes, but also in a large population of terminals which form axospinous and axodendritic asymmetric synapses. The ultrastructural features of these terminals resembled those of glutamatergic corticostriatal boutons. In contrast, very few kainate receptor subunit KA2-containing terminals were encountered. Although the functions of these presynaptic kainate receptors remain to be established, the present data suggest the possibility that they are located to modulate the release of glutamate from cortical afferents in the monkey striatum, and that an abnormal regulation of these presynaptic receptors might be involved in the death of striatal neurons in Huntington's disease. Accordingly, recent findings demonstrated that the variance in the age of onset of Huntington's disease could be attributed to the genotype variation of kainate receptor subunit GluR6 in humans.


Subject(s)
Corpus Striatum/metabolism , Haplorhini/metabolism , Receptors, Kainic Acid/metabolism , Receptors, Presynaptic/metabolism , Animals , Corpus Striatum/ultrastructure , Microscopy, Electron , Presynaptic Terminals/metabolism , Presynaptic Terminals/ultrastructure , Protein Isoforms/metabolism , Tissue Distribution/physiology
9.
Parkinsonism Relat Disord ; 5(4): 193-201, 1999 Dec.
Article in English | MEDLINE | ID: mdl-18591140

ABSTRACT

Anterograde tract-tracing and immunohistochemical methods were used to study projections from the pedunculopontine tegmental nucleus (PPN) to midbrain dopaminergic neurons in the squirrel monkey (Saimiri sciureus). The PPN harbored numerous cholinergic and glutamatergic neurons, as well as neurons that displayed both cholinergic and glutamatergic markers. Injections of anterograde tracer into the PPN led to intense fiber labeling in the substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA). This pedunculonigral projection was partly bilateral. At the electron microscopic level, about 40-60% of the anterogradely labeled terminal boutons were glutamate-positive and formed asymmetric synapses with the dopaminergic neurons of the SNc-VTA complex. These data provide direct evidence for a pedunculonigral glutamatergic projection. This projection may play a crucial role in the control of the firing pattern of SNc-VTA dopaminergic neurons and could be involved in glutamate-mediated excitotoxicity that is believed to lead to SNc cell death in Parkinson's disease.

10.
J Chem Neuroanat ; 15(2): 111-27, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9719363

ABSTRACT

The dorsal raphe nucleus (DR) harbours the largest single collection of serotonin (5-HT)-containing neurons in the brain but also comprises other types of chemospecific neurons. The aim of the present study was to characterise morphologically and immunohistochemically the DR in the squirrel monkey (Saimiri sciureus). The morphology of the DR 5-HT-immunoreactive (ir) neurons was analysed and their distribution compared to that of neurons displaying immunoreactivity for either tyrosine hydroxylase (TH), gamma-aminobutyric acid (GABA), substance P (SP), calbindin-D28k (CB), calretinin (CR) or parvalbumin (PV). The 5-HT-ir neurons were distributed in a highly heterogeneous manner throughout the rostrocaudal extent of the DR. The morphology and density of the 5-HT neurons were found to vary significantly in the major subdivisions of the primate DR, that is, the median, ventral, dorsal, ventrolateral, lateral and caudal subnuclei. Numerous SP-, GABA- and PV-ir neurons occurred in all six subnuclei of the DR. The distribution of SP-ir neurons was largely in register with that of 5-HT-ir neurons. Neurons expressing the other neuronal markers (TH, CB, CR) were not present in all six DR subnuclei and their distribution was either complementary to, or in register with, that of 5-HT-ir neurons. The median subnucleus was unique because it contained all the different types of chemospecific neurons. This study has revealed that the primate DR is chemically highly heterogeneous, a finding that may explain the multifarious influence that this nucleus exerts upon various forebrain structures.


Subject(s)
Raphe Nuclei/anatomy & histology , Raphe Nuclei/metabolism , Animals , Calbindin 2 , Calbindins , Immunohistochemistry , Nerve Tissue Proteins/metabolism , Parvalbumins/metabolism , Raphe Nuclei/enzymology , S100 Calcium Binding Protein G/metabolism , Saimiri , Serotonin/metabolism , Serotonin/physiology , Substance P/metabolism , Tyrosine 3-Monooxygenase/metabolism , gamma-Aminobutyric Acid/metabolism
12.
Brain Res ; 709(2): 311-5, 1996 Feb 19.
Article in English | MEDLINE | ID: mdl-8833768

ABSTRACT

Corticostriatal projections arising from the infragranular layers of the motor and second somatosensory cortices were studied in rats after labeling small pools of neurons with biocytin. Camera lucida reconstruction of 263 fibers arising from laminae V and VI revealed that all corticostriatal projections derive from collaterals of lamina V cells whose main axons descend into the cerebral peduncle. In contrast, lamina VI cells do not branch upon the striatum, but upon the thalamus. Together with the results obtained in previous tracing studies, the present data raise the possibility that no neuron is exclusively corticostriatal. We therefore propose that all corticostriatal projections are collaterals given off by the axons of two types of neurons: layer V cells whose main axon project to the brainstem and/or spinal cord, and layer III cells that project to the contralateral hemisphere.


Subject(s)
Axons/physiology , Corpus Striatum/physiology , Motor Cortex/physiology , Somatosensory Cortex/physiology , Synaptic Transmission , Animals , Brain Mapping , Corpus Striatum/cytology , Female , Lysine/analogs & derivatives , Male , Motor Cortex/cytology , Rats , Rats, Sprague-Dawley , Somatosensory Cortex/cytology , Thalamus/physiology
13.
J Comp Neurol ; 364(2): 231-53, 1996 Jan 08.
Article in English | MEDLINE | ID: mdl-8788247

ABSTRACT

The excitatory amino acid, glutamate, has long been thought to be a transmitter that plays a major role in the control of the firing pattern of midbrain dopaminergic neurons. The present study was aimed at elucidating the anatomical substrate that underlies the functional interaction between glutamatergic afferents and midbrain dopaminergic neurons in the squirrel monkey. To do this, we combined preembedding immunocytochemistry for tyrosine hydroxylase and calbindin D-28k with postembedding immunostaining for glutamate. On the basis of their ultrastructural features, three types (so-called types I, II, and III) of glutamate-enriched terminals were found to form asymmetric synapses with dendrites and perikarya of midbrain dopaminergic neurons. The type I terminals accounted for more than 70% of the total population of glutamate-enriched boutons in contact with dopaminergic cells in the dorsal and ventral tiers of the substantia nigra pars compacta as well as in the ventral tegmental area, whereas 5-20% of the glutamatergic synapses with dopaminergic neurons involved the two other types of terminals. The major finding of our study is that the glutamate-enriched boutons were involved in 70% of the axodendritic synapses in the ventral tegmental area. In contrast, less than 40% of the boutons in contact with dopaminergic dendrites were immunoreactive for glutamate in the dorsal and ventral tiers of the substantia nigra pars compacta. Approximately 50% of the terminals in contact with the perikarya of the different populations of midbrain dopaminergic neurons displayed glutamate immunoreactivity. In conclusion, our findings provide the first evidence that glutamate-enriched terminals form synapses with midbrain dopaminergic neurons in primates. The fact that the proportion of glutamatergic boutons in contact with dopaminergic cells is higher in the ventral tegmental area than in the substantia nigra pars compacta suggests that the different groups of midbrain dopaminergic neurons are modulated differently by extrinsic glutamatergic afferents in primates.


Subject(s)
Glutamic Acid/analysis , Presynaptic Terminals/chemistry , Saimiri/physiology , Substantia Nigra/cytology , Synapses/physiology , Ventral Tegmental Area/cytology , Animals , Antibody Specificity , Biomarkers , Calbindins , Dendrites/chemistry , Dendrites/ultrastructure , Dopamine/physiology , Glutamic Acid/immunology , Immunohistochemistry , Male , Mesencephalon/cytology , Microscopy, Electron , Nerve Tissue Proteins/analysis , Neurons/chemistry , Neurons/ultrastructure , Presynaptic Terminals/ultrastructure , S100 Calcium Binding Protein G/analysis , Synapses/chemistry , Synapses/ultrastructure , Tissue Embedding , Tyrosine 3-Monooxygenase/analysis
14.
J Comp Neurol ; 364(2): 254-66, 1996 Jan 08.
Article in English | MEDLINE | ID: mdl-8788248

ABSTRACT

To verify the possibility that the pedunculopontine nucleus is a source of glutamatergic terminals in contact with midbrain dopaminergic neurons in the squirrel monkey, we used the anterograde transport of Phaseolus vulgaris-leucoagglutinin in combination with preembedding immunohistochemistry for tyrosine hydroxylase and for calbindin D-28k and postembedding immunocytochemistry for glutamate and for gamma-aminobutyric acid. Following tracer injections in the pedunculopontine nucleus, numerous anterogradely labeled fibers emerged from the injection sites to innervate densely the pars compacta of the substantia nigra and ventral tegmental area. The major type of labeled fibers were thin with multiple collaterals and varicosities that established intimate contacts with midbrain dopaminergic neurons. At the electron microscopic level, the anterogradely labeled boutons were medium sized (maximum diameter between 0.9 microns and 2.5 microns) and contained numerous round vesicles and mitochondria. Postembedding immunocytochemistry revealed that 40-60% of anterogradely labeled terminals were enriched in glutamate and formed asymmetric synapses with dendritic shafts of substantia nigra and ventral tegmental area neurons. In triple-immunostained sections, some of the postsynaptic targets to these terminals were found to be dopaminergic. In addition, 30-40% of the anterogradely labeled terminals in both regions displayed immunoreactivity for gamma-aminobutyric acid and, in some cases, formed symmetric synapses with dendritic shafts. In conclusion, our results provide the first ultrastructural evidence for the existence of synaptic contacts between glutamate-enriched terminals from the pedunculopontine nucleus and midbrain dopaminergic neurons in primates. Our results also show that the pedunculopontine nucleus is a potential source of gamma-aminobutyric acid input to this region. These findings suggest that the pedunculopontine nucleus may play an important role in the modulation of the activity of midbrain dopaminergic cells by releasing glutamate or gamma-aminobutyric acid as neurotransmitter.


Subject(s)
Glutamic Acid/analysis , Pons/cytology , Saimiri/physiology , Tegmentum Mesencephali/cytology , gamma-Aminobutyric Acid/analysis , Animals , Biomarkers , Calbindins , Dopamine/physiology , Immunohistochemistry , Male , Mesencephalon/cytology , Microscopy, Electron , Nerve Tissue Proteins/analysis , Neural Pathways , Neurons/chemistry , Neurons/physiology , Neurons/ultrastructure , Phytohemagglutinins , S100 Calcium Binding Protein G/analysis , Substantia Nigra/cytology , Tissue Embedding , Tyrosine 3-Monooxygenase/analysis , Ventral Tegmental Area/cytology
15.
Brain Res ; 698(1-2): 280-4, 1995 Nov 06.
Article in English | MEDLINE | ID: mdl-8581498

ABSTRACT

The striatofugal fiber system in primates is believed to be composed of separate subsystems terminating in either the external (GPe) or internal (GPi) segment of the globus pallidus, or in the substantia nigra (SN). At variance with this concept is the present demonstration of single biocytin-labeled striatofugal axons that arborize in the three major target structures of the striatum in cynomolgus monkeys. Out of nine single-labeled axons that were analyzed in detail, one terminated exclusively in GPc, another in both GPc and GPi, whereas the rest arborized in GPe, GPi and SN. The axons that branched in the three sites had one preferential recipient structure where they arborized profusely and formed typical woolly fibers. These findings suggest that, in contrast to previous beliefs based on results of retrograde double-labeling studies, most striatofugal axons arborize within more than one striatal target structures in primates.


Subject(s)
Axons/ultrastructure , Corpus Striatum/ultrastructure , Globus Pallidus/ultrastructure , Nerve Fibers/ultrastructure , Substantia Nigra/ultrastructure , Animals , Efferent Pathways/ultrastructure , Macaca fascicularis
16.
Brain Res ; 640(1-2): 155-70, 1994 Mar 21.
Article in English | MEDLINE | ID: mdl-7911724

ABSTRACT

The retrograde tracer cholera toxin B subunit (CTb) was used in combination with immunohistochemistry for tyrosine hydroxylase (TH), calbindin D-28k (CaBP), choline acetyltransferase (ChAT) and 5-hydroxytryptamine (5-HT) to determine the distribution and relative proportion of brainstem chemospecific neurons that project to the pallidum in the squirrel monkey (Saimiri sciureus). Large injections of CTb involving both pallidal segments produce numerous retrogradely labeled neurons in the substantia nigra (SN), the pedunculopontine tegmental nucleus (PPN) and the dorsal raphe nucleus (DR). Labeled neurons are distributed uniformly in SN with a slight numerical increase at the junction between the pars compacta (SNc) and the ventral tegmental area (VTA). Retrogradely labeled neurons abound also in PPN, principally in its pars dissipata, whereas other CTb-labeled cells are scattered throughout the rostrocaudal extent of DR. After CTb injection involving specifically the internal pallidal segment (GPi), the same pattern of cell distribution is found in SN, PPN and DR, except that the number of retrogradely labeled cells is lower than after large pallidal complex injections. Approximately 70% of all CTb-labeled neurons in SNc-VTA complex display TH immunoreactivity, whereas 20% are immunoreactive for CaBP. About 39% of all retrogradely labeled neurons in PPN are immunoreactive for ChAT, whereas approximately 38% of the labeled neurons in DR display 5-HT immunoreactivity. Following CTb injection in the external pallidal segment (GPe), the number of labeled cells is much smaller than after GPi injection. The majority of CTb-labeled cells in SNc-VTA complex are located in the lateral half of SNc and approximately 93% of these neurons display TH immunoreactivity compared to 10% that are immunoreactive for CaBP; very few CTb-labeled cells occur in PPN. Retrogradely labeled cells in DR are located more laterally than those that projects to the GPi and about 25% of them are immunoreactive for 5-HT. These results suggest that, in addition to their action at striatal and/or nigral levels, the brainstem dopaminergic, cholinergic and serotoninergic neurons influence the output of the primate basal ganglia by acting directly upon GPi neurons.


Subject(s)
Brain Stem/cytology , Dopamine/physiology , Globus Pallidus/cytology , Neurons, Afferent/physiology , Parasympathetic Nervous System/physiology , Serotonin/physiology , Afferent Pathways/cytology , Afferent Pathways/physiology , Animals , Brain Stem/physiology , Calbindins , Cholera Toxin , Choline O-Acetyltransferase/immunology , Choline O-Acetyltransferase/metabolism , Dopamine/metabolism , Globus Pallidus/physiology , Immunohistochemistry , Male , Parasympathetic Nervous System/cytology , Pons/cytology , Pons/physiology , Raphe Nuclei/cytology , Raphe Nuclei/physiology , S100 Calcium Binding Protein G/immunology , S100 Calcium Binding Protein G/metabolism , Saimiri , Serotonin/immunology , Serotonin/metabolism , Substantia Nigra/cytology , Substantia Nigra/physiology , Tyrosine 3-Monooxygenase/immunology , Tyrosine 3-Monooxygenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...